轻度生理性高血糖诱导健康糖耐量正常者肝脏胰岛素抵抗
结果显示基础EGP由2.04±0.08升至3.06±0.29 mg/kgffm·min(P<0.005),肝脏胰岛素抵抗指数由20.1±1.8升至51.7±6.6(P<0.005)。结论:短期持续生理性高血糖即可增加基础肝糖生成并诱导肝脏胰岛素抵抗。
要点
- 48小时持续生理性高血糖使健康糖耐量正常者基础肝糖生成增加。
- 肝脏胰岛素抵抗指数在高血糖后显著升高,有无糖尿病家族史者均如此。
- 提示糖毒性参与2型糖尿病肝糖生成增加的病理过程。
核心结论
- 持续48小时的生理性高血糖可增加健康糖耐量正常者的基础肝糖生成并诱导肝脏胰岛素抵抗,为糖毒性在2型糖尿病肝糖生成增加中的作用提供证据。
研究设计与样本
- 以3-3H-葡萄糖测定内源性葡萄糖生成(EGP)。
主要发现
- 48小时葡萄糖输注后基础EGP由均值±SEM 2.04±0.08升至3.06±0.29 mg/kgffm·min(P<0.005)。
- 肝脏胰岛素抵抗指数(基础EGP×空腹血浆胰岛素)由20.1±1.8升至51.7±6.6(P<0.005),有和无糖尿病家族史者均升高。
临床怎么用
- 对糖耐量正常者,短期血糖轻度升高即应关注肝脏胰岛素敏感性变化。
- 有糖尿病家族史者同样可出现高血糖诱导的肝脏胰岛素抵抗,需重视早期血糖管理。
局限性
- 研究对象为糖耐量正常者,结果外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Chronic hyperglycemia worsens skeletal muscle insulin resistance and β-cell function. However, the effect of sustained physiologic hyperglycemia on hepatic insulin sensitivity is not clear. OBJECTIVE: To examine the effect of sustained physiologic hyperglycemia (similar to that observed in patients with type 2 diabetes) on endogenous (primarily reflecting hepatic) glucose production (EGP) in healthy individuals. DESIGN: Volunteers participated in a three-step hyperinsulinemic (10, 20, 40 mU/m2 per minute) euglycemic clamp before and after a 48-hour glucose infusion to increase plasma glucose concentration by ∼40 mg/dL above baseline. EGP was measured with 3-3H-glucose before and after chronic glucose infusion. PARTICIPANTS: Sixteen persons with normal glucose tolerance [eight with and eight without a family history (FH) of diabetes] participated in the study. MAIN OUTCOME MEASURE: EGP. RESULTS: Basal EGP increased following 48 hours of glucose infusion (from a mean ± SEM of 2.04 ± 0.08 to 3.06 ± 0.29 mg/kgffm⋅ min; P < 0.005). The hepatic insulin resistance index (basal EGP × fasting plasma insulin) markedly increased following glucose infusion (20.1 ± 1.8 to 51.7 ± 6.6; P < 0.005) in both FH+ and FH- subjects. CONCLUSION: Sustained physiologic hyperglycemia for as little as 48 hours increased the rate of basal hepatic glucose production and induced hepatic insulin resistance in health persons with normal glucose tolerance, providing evidence for the role of glucotoxicity in the increase in hepatic glucose production in type 2 diabetes.
引用
- Tripathy D, Merovci A, Basu R, et al. Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants. J Clin Endocrinol Metab. 2019. PMID: 30789980. doi:10.1210/jc.2018-02304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。